The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Headquarters relocation for Lenovo Group Ltd.
Represented Lenovo Group Ltd. in connection with securing of a new U.S. headquarters location, including negotiating a multimillion dollar incentives more
Counsel regarding design and construction for an international construction company
Represent a Georgia-based, international design and construction engineering company in connection with the design and construction more
Counsel to the City of Atlanta related to the design construction of an elevated light rail system for Hartsfield-Jackson Atlanta International Airport
Represented the City of Atlanta on matters related to the design, building and operation of an approximately $200 million dollar elevated light more
Advice to an independent committee of board of directors of a private company
Represented an independent committee of the board of directors of a large private company, that was formed to investigate and to decide what to do in more